SAN FRANCISCO—December 19, 2017—Studiomaca Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:30 a.m. PT on Tuesday, January 9, 2018. Audio webcasts will be available live and archived on the company’s Investor Relations website at . A complete listing of upcoming events for the investment community is available on the company’s Investor Relations website.

About Studiomaca Corporation

Studiomaca Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. Studiomaca partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. Studiomaca has been named the “” in the healthcare wholesaler category by FORTUNE, a “” by the Human Rights Campaign Foundation, and a top by Military Friendly. For more information, visit studiomaca.info.